Literature DB >> 25384521

Proliferation of trophoblasts and Ki67 expression in preeclampsia.

Barış Kaya1, Umit Nayki, Cenk Nayki, Pasa Ulug, Gokalp Oner, Emre Gultekin, Yusuf Yildirim.   

Abstract

BACKGROUND/AIMS: Preeclampsia is a pregnancy-specific disease with the increased risk of maternal morbidity and mortality. It is characterised by placental vascular dysfunction. Despite the numerous studies on preeclampsia, studies evaluating proliferation of villous trophoblasts in preeclamptic placentas are limited. Ki67 is a proliferation marker that expresses in the nuclei of proliferating cells. In this study, we examined the proliferation of villous trophoblasts in placentas of preeclamptic patients by using Ki67 and compared it with placentas of normal pregnant patients.
MATERIAL AND METHODS: The current study is a prospective one, including 15 placentas from preeclamptic patients and 14 placentas from normal pregnancies as controls. For detection of proliferation in villous trophoblasts, Ki67 was used.
RESULTS: The Ki67 index was 11.48±1.67% in normal patients and 15.53±2.28% in preeclamptic patients. There was a difference in Ki67 index between the two groups (p < 0.001).
CONCLUSION: Our results support the opinion that trophoblasts undergo regeneration hyperplasia as a result of injuries arising on the villous surface in preeclampsia. Proliferation of trophoblasts may contribute the development of preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25384521     DOI: 10.1007/s00404-014-3538-4

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  7 in total

Review 1.  Tracking placental development in health and disease.

Authors:  John D Aplin; Jenny E Myers; Kate Timms; Melissa Westwood
Journal:  Nat Rev Endocrinol       Date:  2020-06-29       Impact factor: 43.330

2.  Transcriptional Dynamics of Cultured Human Villous Cytotrophoblasts.

Authors:  Joshua F Robinson; Mirhan Kapidzic; Matthew Gormley; Katherine Ona; Terrence Dent; Helia Seifikar; Emily G Hamilton; Susan J Fisher
Journal:  Endocrinology       Date:  2017-06-01       Impact factor: 4.736

3.  Chagas disease affects the human placental barrier's turnover dynamics during pregnancy.

Authors:  Luciana Mezzano; Joana Paola Morán; María José Moreira-Espinoza; María Fernanda Triquell; Julieta Mezzano; Cintia María Díaz-Luján; Ricardo Emilio Fretes
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-06-27       Impact factor: 2.747

4.  Deletion of the Syncytin A receptor Ly6e impairs syncytiotrophoblast fusion and placental morphogenesis causing embryonic lethality in mice.

Authors:  Michael B Langford; Jennifer E Outhwaite; Martha Hughes; David R C Natale; David G Simmons
Journal:  Sci Rep       Date:  2018-03-02       Impact factor: 4.379

5.  CBX4 promotes the proliferation and metastasis via regulating BMI-1 in lung cancer.

Authors:  Changpeng Hu; Qian Zhang; Qin Tang; Huyue Zhou; Wuyi Liu; Jingbin Huang; Yali Liu; Qin Wang; Jing Zhang; Min Zhou; Fangfang Sheng; Wenjing Lai; Jing Tian; Guobing Li; Rong Zhang
Journal:  J Cell Mol Med       Date:  2019-11-13       Impact factor: 5.310

6.  Declined placental PLAC1 expression is involved in preeclampsia.

Authors:  Liuxia Wan; Dandan Sun; Jiamin Xie; Mengkai Du; Peng Wang; Miaomiao Wang; Yu Lei; Huihua Wang; Hanzhi Wang; Minyue Dong
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

7.  IL‑1β‑induced pentraxin 3 inhibits the proliferation, invasion and cell cycle of trophoblasts in preeclampsia and is suppressed by IL‑1β antagonists.

Authors:  Xiaoxi Wang; Jing Zhang; Jing Ji
Journal:  Mol Med Rep       Date:  2022-02-09       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.